Clinical Trials, Containment, Genotype and Immune Response

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Trials

Containment

Genotype

Immune Response

Evolution in Hepatitis B and C Virus: Can we expect success similar to Hepatitis C in Hepatitis B as well?

Delveinsight

DECEMBER 13, 2020

Even though clinical trial results were promising, adverse events and serious complications were observed. Hepatitis C treatment options, without a doubt, have improved significantly, including pan-genotypic medications that are used to treat all genotypes and subtypes. and GT2 and GT3 with ribavirin. in January 2019.

Genotype

Genotype FDA Approval DNA Drugs

Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?

XTalks

SEPTEMBER 15, 2020

A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. So, this really validates what we already knew and now we have prospective results supporting that [from this trial].”.

Vaccination

Vaccination Vaccine Insulin Trials

Clinical Research Informer

Evolution in Hepatitis B and C Virus: Can we expect success similar to Hepatitis C in Hepatitis B as well?

Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?

Stay Connected